These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24612942)

  • 1. Administration of anticancer drugs: exposure in hospital nurses.
    Rioufol C; Ranchon F; Schwiertz V; Vantard N; Joue E; Gourc C; Gauthier N; Guedat MG; Salles G; Souquet PJ; Favier B; Gilles L; Freyer G; You B; Trillet-Lenoir V; Guitton J
    Clin Ther; 2014 Mar; 36(3):401-7. PubMed ID: 24612942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a safe infusion device on reducing occupational exposure of nurses to antineoplastic drugs: a comparative prospective study. Contamoins-1.
    Forges F; Blanc E; Raymond B; Menguy S; Macé A; Hugues M; Macron C; Bouleftour W; Tinquaut F; Guitton J; Simoëns X
    Int Arch Occup Environ Health; 2021 Aug; 94(6):1317-1325. PubMed ID: 33733326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational exposure to cytotoxic drugs in two UK oncology wards.
    Ziegler E; Mason HJ; Baxter PJ
    Occup Environ Med; 2002 Sep; 59(9):608-12. PubMed ID: 12205233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pooled analysis to study trends in exposure to antineoplastic drugs among nurses.
    Fransman W; Peelen S; Hilhorst S; Roeleveld N; Heederik D; Kromhout H
    Ann Occup Hyg; 2007 Apr; 51(3):231-9. PubMed ID: 17337460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.
    Villa A; Molimard M; Bignon E; Martinez B; Rouyer M; Mathoulin-Pelissier S; Baldi I; Verdun-Esquer C; Canal-Raffin M
    BMJ Open; 2019 Nov; 9(11):e033040. PubMed ID: 31712349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
    Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study.
    Fransman W; Vermeulen R; Kromhout H
    Ann Occup Hyg; 2004 Apr; 48(3):237-44. PubMed ID: 15059800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.
    Acramel A; Fouque J; Blondeel-Gomes S; Huguet S; Rezai K; Madar O; Escalup L
    Ann Work Expo Health; 2022 Nov; 66(9):1215-1223. PubMed ID: 35596678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new, validated wipe-sampling procedure coupled to LC-MS analysis for the simultaneous determination of 5-fluorouracil, doxorubicin and cyclophosphamide in surface contamination.
    Bobin-Dubigeon C; Amiand M; Percheron C; Audeval C; Rochard S; Leynia P; Bard JM
    J Anal Toxicol; 2013 Sep; 37(7):433-9. PubMed ID: 23828102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics.
    Rossignol E; Amiand MB; Sorrieul J; Bard JM; Bobin-Dubigeon C
    J Pharmacol Toxicol Methods; 2020; 101():106652. PubMed ID: 31734280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPLC-MS/MS method for simultaneous determination of cyclophosphamide, docetaxel, doxorubicin and 5-fluorouracil in surface samples.
    da Silva CB; Julio IP; Donadel GE; Martins I
    J Pharmacol Toxicol Methods; 2016; 82():68-73. PubMed ID: 27521053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators.
    Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D
    Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
    Roland C; Caron N; Bussières JF
    J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurses' internal contamination by antineoplastic drugs in hospital centers: a cross-sectional descriptive study.
    Villa A; Molimard M; Sakr D; Lassalle R; Bignon E; Martinez B; Rouyer M; Mathoulin-Pelissier S; Baldi I; Verdun-Esquer C; Canal-Raffin M
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1839-1850. PubMed ID: 34021808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces.
    Mucci N; Dugheri S; Farioli A; Garzaro G; Rapisarda V; Campagna M; Bonari A; Arcangeli G
    Med Pr; 2020 Sep; 71(5):519-529. PubMed ID: 32667290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual contamination in antineoplastic drug packaging.
    E Silva LS; Machado CDSB; Linden R; Antunes MV; da Silva LC; Wayhs CAY; Capp E; Ness SLR
    J Oncol Pharm Pract; 2023 Dec; 29(8):1862-1867. PubMed ID: 36659825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and oxaliplatin surface contamination in intensive care units (ICUs) and hospital wards during attendance of HIPEC patients.
    Schenk KE; Schierl R; Angele M; Burkhart-Reichl A; Glockzin G; Novotny A; Nowak D
    Int Arch Occup Environ Health; 2016 Aug; 89(6):991-6. PubMed ID: 27142971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs.
    Maeda S; Miyawaki K; Matsumoto S; Oishi M; Miwa Y; Kurokawa N
    Yakugaku Zasshi; 2010 Jun; 130(6):903-10. PubMed ID: 20519870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.